Literature DB >> 4017833

Dissociation of duodenogastric marker reflux and bile salt reflux.

S A Müller-Lissner, C Fraass.   

Abstract

Duodenogastric reflux of a perfused marker and bile salt reflux, as well as emptying of fasting gastric contents and gastric secretion, were measured simultaneously in six healthy volunteers. Each of the subjects was studied three times in randomized order during intravenous administration of either saline or atropine (40 micrograms/kg/4 hr) or cerulein (360 ng/kg/4 hr). Fractional gastric emptying rate was inhibited from 4.57%/min +/- 0.50 SE to 0.70 +/- 0.15 by atropine (P less than 0.001) and to 1.80 +/- 0.29 by cerulein (P less than 0.005). Atropine increased reflux of duodenally perfused phenol red from 0.95 +/- 0.28 to 26.09 +/- 4.98% (P less than 0.005) without affecting bile salt reflux (0.44 +/- 0.07 vs 0.51 +/- 0.17 mumol/min). In contrast, cerulein did not significantly affect duodenogastric marker reflux (2.23 +/- 0.82%) but increased bile salt reflux to 0.94 +/- 0.16 mumol/min (P less than 0.05). It is concluded that reflux of duodenal contents and reflux of bile salts do not necessarily parallel each other. This may produce considerable confusion by apparently contradictory results in studies on duodenogastric reflux.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017833     DOI: 10.1007/bf01320486

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

Review 1.  Actions of gastrointestinal hormones and related peptides on the motor function of the biliary tract.

Authors:  T M Lin
Journal:  Gastroenterology       Date:  1975-10       Impact factor: 22.682

Review 2.  Progress report: caerulein.

Authors:  V Erspamer
Journal:  Gut       Date:  1970-01       Impact factor: 23.059

3.  Pyloric-sphincter dysfunction in patients with gastric ulcer.

Authors:  R S Fisher; S Cohen
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

4.  Increased reflux of bile into the stomach in patients with gastric ulcer.

Authors:  J Rhodes; D E Barnardo; S F Phillips; R A Rovelstad; A F Hofmann
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

5.  Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat.

Authors:  J E Valenzuela; C Defilippi
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

6.  Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion.

Authors:  P C Lederer; R Thiemann; J Femppel; W Domschke; G Lux
Journal:  Scand J Gastroenterol Suppl       Date:  1982

7.  Effect of intestinal hormones and peptides on intragastric pressure in dogs.

Authors:  J E Valenzuela
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

8.  Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer.

Authors:  S A Müller-Lissner; C J Fimmel; A Sonnenberg; N Will; W Müller-Duysing; F Heinzel; R Müller; A L Blum
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

9.  Interdigestive biliary output in man: relationship to fluctuations in plasma motilin and effect of atropine.

Authors:  T Svenberg; N D Christofides; M L Fitzpatrick; F Areola-Ortiz; S R Bloom; R B Welbourn
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

10.  Inhibition of interdigestive contractile activity in the stomach by peptide YY in Heidenhain pouch dogs.

Authors:  T Suzuki; M Nakaya; Z Itoh; K Tatemoto; V Mutt
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

View more
  9 in total

1.  Intragastric pH monitoring is unsuitable for diagnosis of duodenogastric reflux.

Authors:  J Hostein; R Bost
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  Gastric fluid volume, pH, and emptying in elective inpatients. Influences of narcotic-atropine premedication, oral fluid, and ranitidine.

Authors:  J R Maltby; N Koehli; A Ewen; E A Shaffer
Journal:  Can J Anaesth       Date:  1988-11       Impact factor: 5.063

3.  Transpyloric fluid movement and antroduodenal motility in patients with gastro-oesophageal reflux.

Authors:  P M King; A Pryde; R C Heading
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

4.  Fiberoptic technique for 24-hour bile reflux monitoring. Standards and normal values for gastric monitoring.

Authors:  M Fein; K H Fuchs; T Bohrer; S M Freys; A Thiede
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

5.  Variability in the composition of physiologic duodenogastric reflux.

Authors:  K H Fuchs; J Maroske; M Fein; H Tigges; M P Ritter; J Heimbucher; A Thiede
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

6.  Cisapride offsets dopamine-induced slowing of fasting gastric emptying.

Authors:  S A Müller-Lissner; C Fraas; A Härtl
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

7.  Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring.

Authors:  K H Fuchs; T R DeMeester; R A Hinder; H J Stein; A P Barlow; N C Gupta
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

8.  Healthy controls have as much bile reflux as gastric ulcer patients.

Authors:  N E Schindlbeck; C Heinrich; F Stellaard; G Paumgartner; S A Müller-Lissner
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

9.  Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.

Authors:  J Rezende-Filho; C Di Lorenzo; C P Dooley; J E Valenzuela
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.